You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
If, in the same pathway, there are two MFs where the enabled by is the same (interactor A) and the target is the same (interactor B), you should accept one over the other according to precedence rules, and if there’s no rule just report an error and we’ll review it. The one precedence rule we can state now is that protein kinase activity should be chosen over protein binding. So for ATM acting on ABL1, you’ll only have one activity (protein kinase).
The text was updated successfully, but these errors were encountered:
I added a filter specifically for this rule that removes all non-"protein kinase activity" interaction lines if the only lines are either protein kinase activity or protein binding.
So for ATM to ABL1, this removed the extra "protein binding" relation. Before:
If, in the same pathway, there are two MFs where the enabled by is the same (interactor A) and the target is the same (interactor B), you should accept one over the other according to precedence rules, and if there’s no rule just report an error and we’ll review it. The one precedence rule we can state now is that protein kinase activity should be chosen over protein binding. So for ATM acting on ABL1, you’ll only have one activity (protein kinase).
The text was updated successfully, but these errors were encountered: